Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.
Televitas 3A
€30,500
total amount raised in round
- Eligible for a tax reduction
Revenue & Business Model
Televitas operates a hybrid model that combines recurring revenue streams with flexible project-based income. This structure supports both financial resilience and scalability as the company targets healthcare institutions, employers, and insurers.
Primary Revenue Streams
- Platform Licensing
- Pro version for hospitals and large providers with advanced analytics and AI tools.
- Light version for care centers and smaller institutions.
- Communication Hub (Hardware-as-a-Service)
- Offered via monthly subscription for seamless integration into home and care settings.
- Offered via monthly subscription for seamless integration into home and care settings.
- Data Connectors
- Enable integration with wearables, apps, and sensors.
- Delivered through scalable, usage-based subscriptions.
Secondary Revenue Streams
- Digital Pricing Service : Transaction-based revenue tied to automated billing and reimbursement of remote care.
- Consulting & Integration Services : Time-and-material based support for platform implementation in healthcare environments.
- Custom Data Services : Development of predictive AI models and tailored reporting, charged per project or daily rate.
Televitas owns 100% of the intellectual property across software, AI models, and hardware components—ensuring control and long-term value capture.

Business Model Logic
Televitas delivers value across four key segments:
- Healthcare Providers: Integration with EHR systems and real-time data access improve patient outcomes and operational efficiency.
- Healthcare Professionals: Centralized dashboards help track patient compliance and personalize care.
- Employers (HR departments): Health monitoring and predictive analytics reduce absenteeism and burnout risk.
- Insurers: Access to real-time lifestyle and health metrics enables personalized risk models and early interventions.
Each segment is supported by a pricing strategy that blends:
- Subscription fees (based on users or usage volume)
- One-time onboarding/integration fees
- Add-on pricing for advanced analytics, visualizations, or white-labeled services
Scalability & Growth Potential
- Cloud-native architecture ensures rapid scaling across care institutions, employers, and national borders.
- Subscription-based income builds predictable, recurring revenue.
- Consulting and integration deepen customer retention and fuel long-term platform usage.
- Strategic partnerships with wearable manufacturers, pharma, and public health institutions create additional monetization layers (e.g. licensing, data agreements).
Commercial Traction
A pilot hybrid care project with residential care centers—focused on type 2 diabetes—has already demonstrated ROI:
- Monthly savings per patient: ~€83
- Pilot return: ~€413 net per month (10 patients)
- Full-scale rollout (2,600 patients):
- Monthly savings: €216,667
- Televitas cost: €58,200
- Net benefit: ~€158,000/month
Reimbursement is supported through NIHII codes, digital consultation policies, and partnerships with care groups and regional authorities.
Business plan 5+
Televitas combines the recurring revenue model of a SaaS platform with the real-world urgency of digital healthcare transformation. Backed by public reimbursement frameworks, growing demand for hybrid care, and a mature IP portfolio, it is positioned to:
- Deliver strong EBITDA growth starting in year 3.
- Achieve high-margin, scalable revenue through a subscription-first model.
- Expand internationally with controlled, modular rollouts across public and private health systems.
With proof points in place and market expansion already underway, Televitas offers investors access to a resilient, tech-enabled health platform aligned with macro trends in aging, digitization, and preventive care.

Looking Ahead
- Expand platform licensing to more care pathways: geriatric, pediatric, chronic care.
- Launch prevention programs via Health Arena consortium (Q2 2025).
- Target international markets (NL, EU, US) via existing partnerships and EU health innovation funding.
TAX SHELTER 45%
Investments in this company benefit from a 45% personal income tax reduction. Read more…A remaining amount of €320,000 is available for the Tax Shelter benefit.
Raise summary
Crowd investments | €26,000 |
Committed by others | €4,500 |
Amount raised | €30,500 |
Minimum round | €25,000 |
Maximum round | €450,000 |
Shares in the company (total round) | 13.043% |
Pre-money valuation | €3,000,000 |
Post-money valuation min. | €3,025,000 |
Post-money valuation max. | €3,450,000 |